Document text
Principal Investigator: Priyamvada Acharya
Organization: DUKE UNIVERSITY
Fiscal Year: 2021
Award: $771,293
Funding agency: National Institute of Allergy and Infectious Diseases
TThe ongoing global pandemic of the novel SARS-CoV-2 coronavirus (CoV) presents an urgent need for development of effective preventative and treatment therapies. The viral-host cell fusion (S) protein spike is a prime target for such therapies owing to its critical role in the virus lifecycle. The S protein is divided into two regions: the N-terminal S1 domain that caps the C-terminal S2 fusion domain. Binding to host receptor via the Receptor Binding Domain (RBD) in S1 is followed by proteolytic cleavage of the spike by host proteases. This leads dramatic conformational transitions resulting in S1 shedding and exposure of the fusion machinery in S2, culminating in host-cell entry. Class I fusion proteins such as the CoV S protein that undergo large conformational changes during the fusion process must, by necessity, be highly flexible and dynamic. Indeed, cryo-EM structures of the SARS-CoV-2 spike reveal considerable flexibility and dynamics in the S1 domain, especially around the RBD that exhibits two discrete conformational states – a “down” state that is shielded from receptor binding, and an “up” state that is receptor-accessible. The overall goals of this study are to use our robust, high-throughput computational and experimental pipeline to define the detailed trajectory of the
“down” to “up” transition of the SARS-CoV-2 S protein, identify early metastable intermediates in the fusion pathway, and exploit their structures and dynamics for identifying drug and vaccine candidates that target SARS-CoV-2. A wealth of structural information on CoV spike proteins, including recently determined cryo-EM structures of the SARS-CoV-2 spike, provides a rich source of detailed data from which to begin precise examination of macromolecular transitions underlying triggering of this fusion machine
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Antibodies><Binding><C-terminal><COVID-19><COVID-19 virus><COVID19><COVID19 virus><CV-19><CV19><Cell Body><Cell fusion><Cells><Chimera Protein><Chimeric Proteins><CoV S protein><CoV glycoprotein S><CoV spike glycoprotein><CoV spike protein><CoV-2><CoV2><Coronaviridae><Coronavirus><Coronavirus glycoprotein S><Coronavirus spike protein><Cryo-electron Microscopy><Cryoelectron Microscopy><Data><Development><Disease><Disorder><Electron Cryomicroscopy><Esteroproteases><Exhibits><Fusion Protein><Goals><Immune system><Ligand Binding><Microscopy><Molecular Configuration><Molecular Conformation><Molecular Interaction><Molecular Stereochemistry><Motion><Movement><N-terminal><NH2-terminal><Pathway interactions><Peptidases><Peptide Hydrolases><Play><Preventative treatment><Preventive treatment><Process><Protease Gene><Proteases><Proteinases><Proteins><Proteolytic Enzymes><Receptor Protein><Resolution><Role><SARS><SARS corona virus 2><SARS coronavirus disease><SARS-CoV disease><SARS-CoV-2><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV disease><Severe Acute Respiratory Syndrome coronavirus disease><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Source><Specificity><Structure><Surface><Vaccines><Viral><Virus><Wuhan coronavirus><allergic/immunologic body system><allergic/immunologic organ system><body movement><computational tools><computerized tools><conformation><conformational conversion><conformational state><conformational transition><corona virus><corona virus disease 2019><coronavirus S protein><coronavirus disease 2019><coronavirus disease 2019 virus><coronavirus spike glycoprotein><cryo-EM><cryoEM><develop a vaccine><development of a vaccine><developmental><drug candidate><flexibility><flexible><hCoV19><nCoV2><novel><pandemic><pandemic disease><pathway><receptor><receptor binding><receptor bound><social role><therapeutic agent development><therapeutic development><vaccine candidate><vaccine development><vaccine formulation>